For more updates follow Grant Thornton Bharat on WhatsApp
Explore how an AI-first approach can transform India’s public sector, enabling data-driven governance, improved service delivery and scalable digital infrastructure.
India stands at a decisive inflection point in the evolution of healthcare in India. Over the past decade, the country has built healthcare access at population scale through landmark reforms such as Ayushman Bharat, expanded public health financing, and the creation of a nationally interoperable digital health infrastructure India.
Pharma and healthcare deal activity in Q1 2026 reflects steady volumes alongside a more measured approach to capital deployment.
In light of the ongoing COVID-19 crisis, multinationals are readjusting their supply chains and business models to meet the ever-changing demands of the new ‘now’.
Due to the ongoing COVID-19 crisis, businesses are expected to face considerable liquidity challenges due to sharp reduction in economic activity, amidst concerns of weaker demand for at least the next few quarters.
With major cities across the globe enforcing lockdowns to manage COVID-19 crisis, work from home or remote working has become the new normal.
In light of the ongoing COVID-19 crisis, the depressed business environment is expected to last a few quarters.
In light of the 21-day lockdown announced due to the Coronavirus disease (COVID-19) pandemic, the Department of Promotion of Industry and Internal Trade (DPIIT) has issued guidelines for the State authorities not to obstruct operations/call for closure of food processing units.
In light of the ongoing COVID-19 crisis, the government has recently announced a slew of tax and regulatory relief measures to provide a compliance breather to businesses.
The ongoing Coronavirus (COVID-19) disease pandemic has severely impacted the Indian economy. India Inc. is facing major challenges with the financial year closing and taxpayers therefore need to be more vigilant to minimise any potential impact.
The Coronavirus (COVID-19) disease pandemic has led to massive changes in how organisations operate.
As the coronavirus disease (COVID-19) pandemic disrupts global value chains, the Indian pharmaceutical industry is staring at multiple challenges.
This publication highlights some of the key financial reporting implications that businesses need to consider in preparation of their financial statements during COVID-19 crisis.
The Indian tax and regulatory space is changing at an unprecedented rate. We are witnessing policy announcements, legislative changes, judicial precedents and clarifications almost daily.
We are pleased to present the Monthly Dealtracker that captures the recent deal activities in India.
As Coronavirus or COVID-19 takes its toll on the world, we at Grant Thornton India are taking every possible step to help our people, clients and communities tide over this challenge and emerge stronger.
We are pleased to present Valuation Pulse for the third quarter of FY 2020*.
This edition of Auto Bytes looks at the impact of COVID-19 on the sector and the learnings it can draw from this crisis.
This edition covers updates for the month of February 2020. We hope you find this bulletin informative and useful.